1. Does your trust use the following biosimilar biologic therapies, and if possible how many patients are currently being treated ?
Adalimumab [Hyrimoz] No/Yes [if Yes number .....] NO
Adalimumab [Amgevita] No/Yes [if Yes number .....] YES – Less than 5*
Adalimumab [Imraldi] No/Yes [if Yes number .....] NO
Adalimumab [Hulio] No/Yes [if Yes number .....] NO
Etanercept [Benepali] No/Yes [if Yes number .....] YES - 363
Etanercept [Erelzi] No/Yes [if Yes number .....] NO
Infliximab [Inflectra] No/Yes [if Yes number .....] YES - 149
Infliximab [Remsima] No/Yes [if Yes number .....] NO
Infliximab [Flixabi] No/Yes [if Yes number .....] NO
2. Within your rheumatology department;
a. how many patients in the year 2018 were treated with a biologic or JAK2
b. how many patients in the year 2018 were treated with a DMARD [for example azathioprine, ciclosporin, methotrexate, hydroxychloroquine, leflunomide, sulfasalazine or minocycline]
3. Within your dermatology department;
a. how many patients in the year 2018 were treated with a biologic or JAK2
b. how many patients in the year 2018 were treated with a DMARD [for example azathioprine, ciclosporin, methotrexate, hydroxychloroquine, leflunomide, sulfasalazine or minocycline]
4. Within your gastrenterology department;
a. how many patients in the year 2018 were treated with a biologic or JAK2
b. how many patients in the year 2018 were treated with a DMARD [for example azathioprine, ciclosporin, methotrexate, hydroxychloroquine, leflunomide, sulfasalazine or minocycline]
Due to how the data is recorded on the system, it is not possible to provide this split by department. We are able to provide totals for this only.
2a, 3a and 4a – 1998 patients
2b, 3b and 4b – 2030 patients
5. Does your trust record the DAS score electronically on the patient records?,
If so how many are DAS 5+ No/Yes [if Yes number .....] NO
* Please note that we are unable to provide the data for categories where there are less than 5 patients involved in the question, as the disclosure of data could lead to an individual patient being identified or personal data being disclosed in breach of the Data Protection Act.